Priority of experimental evidence.

Abstract

HomeCirculation ResearchVol. 93, No. 3Priority of Experimental Evidence Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBPriority of Experimental Evidence Shigeru Nishizawa Shigeru NishizawaShigeru Nishizawa Hamamatsu, Japan, [email protected] Search for more papers by this author Originally published8 Aug 2003https://doi.org/10.1161/01.RES.0000087334.44183.A6Circulation Research. 2003;93:e25To the Editor:The authors of a recent article that appeared in Circulation Research1 described that “there is no information available regarding the mechanism by which SAH activates the Rho/Rho kinase or PKC pathways” (page 810). I would like to say that such a description is incorrect. There is a history of experiments to identify the relationship between the roles of protein kinase C (PKC) and the mechanism of vasospasm after subarachnoid hemorrhage (SAH). In particular, we have extensively investigated the roles of PKC in the development and maintenance of vasospasm after SAH, as listed in the References.2–5 Wickman et al1 should have discussed the history of the experiments regarding “the mechanism by which SAH activates PKC pathways.” Since we clarified the roles of PKC in the mechanism of vasospasm, we carefully examined which PKC isoforms are expressed in canine basilar artery and which ones are involved in the development and maintenance of vasospasm with Western blotting analysis, just as the authors did. We detected four PKC isoforms in canine basilar artery (PKCα, δ, ζ, η). Among these four PKC isoforms, PKCδ is closely related with the initiation and PKCα with the maintenance of vasospasm in a “two-hemorrhage” canine model (in situ 1-week study). Because the antibodies for PKC isoforms are derived from a different space (rat brain), we showed the specificity of the bands expressed in Western blotting by elimination of these bands using antibody-specific synthetic peptides. I believe that it is not good enough to show the positive control using rat brain, but rather to show the elimination of bands, just as we did, in order to say it is specific. From these points of view, I think that Wickman et al should have discussed the priority of experimental evidence regarding the role of PKC isoforms in the mechanism of vasospasm after SAH by citing previously published studies. Wickman et al emphasized the roles of PKCε and PKCα in the mechanism of vasospasm. The authors should also have discussed the reasons why they obtained such different experimental evidence from ours. The authors’ experimental periods were 1.5 hours in the isometric tension study and 60 minutes in cultured smooth muscles cells. The period of clinical vasospasm lasts for 1 or 2 weeks. In addition, it is not deniable that multiple substances could be candidates to induce vasospasm besides oxyhemoglobin. The authors’ explanation based on their evidence for the mechanism of vasospasm might be a mechanism of the initiation of vasospasm, and a property of rabbit basilar artery to only oxyhemoglobin. However, it cannot be relevant for a mechanism of the sustained cerebral arterial contraction like vasospasm after SAH.1 Wickman G, Lan C, Vollrath B. Functional roles of the Rho/Rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm. Circ Res. 2003; 92: 809–816.LinkGoogle Scholar2 Nishizawa S, Nezu N, Uemura K. Direct evidence for a key role of protein kinase C in the development of vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992; 76: 635–639.CrossrefMedlineGoogle Scholar3 Nishizawa S, Peterson JW, Shimoyama I, Uemura K. Relation between protein kinase C and calmodulin systems in cerebrovascular contraction: investigation of the pathogenesis of vasospasm after subarachnoid hemorrhage. Neurosurgery. 1992; 31: 711–716.MedlineGoogle Scholar4 Nishizawa S, Yamamoto S, Yokoyama T, Ryu H, Uemura K. Chronological changes of arterial diameter, cGMP and protein kinase C in the development of vasospasm. Stroke. 1995; 26: 1916–1921.CrossrefMedlineGoogle Scholar5 Nishizawa S, Obara K, Nakayama K, Koide M, Yokoyama T, Yokota N, Ohta S. Protein kinase Cδ and α are involved in the development of vasospasm after subarachnoid hemorrhage. Eur J Pharmacol. 2000; 398: 113–119.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails August 8, 2003Vol 93, Issue 3 Advertisement Article InformationMetrics https://doi.org/10.1161/01.RES.0000087334.44183.A6PMID: 12907664 Originally publishedAugust 8, 2003 PDF download Advertisement